Jazz Pharmaceuticals (JAZZ) Goodwill (2010 - 2026)

Jazz Pharmaceuticals has reported Goodwill for 17 years, with the latest figure at $1.8 billion in Q1 2026.

• For the quarter ending Q1 2026, Goodwill rose 2.55% year-over-year to $1.8 billion; the trailing twelve-month figure through Mar 2026 stood at $1.8 billion (up 2.55% YoY), and the FY2025 full-year result was $1.8 billion, up 6.58% from the prior year.
• Goodwill for Q1 2026 stood at $1.8 billion, down from $1.8 billion in the prior quarter.
• The five-year high for Goodwill was $1.8 billion in Q2 2025, with the low at $1.6 billion in Q3 2022.
• Average Goodwill over 5 years is $1.7 billion, with a median of $1.7 billion recorded in 2023.
• Peak annual rise in Goodwill reached 89.95% in 2022, while the deepest fall reached 13.89% in 2022.
• Tracing JAZZ's Goodwill over 5 years: stood at $1.7 billion in 2022, then advanced by 3.57% to $1.8 billion in 2023, then decreased by 2.1% to $1.7 billion in 2024, then gained by 6.58% to $1.8 billion in 2025, then decreased by 1.33% to $1.8 billion in 2026.
• The last three Goodwill figures came in at $1.8 billion (Q1 2026), $1.8 billion (Q4 2025), and $1.8 billion (Q3 2025), per Business Quant data.

Peer Comparison